Everything You Always Wanted to Know About Clinical Research in China, But Were Afraid to Ask

After scandals involving tainted toothpaste, poisonous pet food, adulterated milk, contaminated heparin, and counterfeit medicines, and a thriving trade in organs, one shudders to imagine how well human subjects are protected in drug studies performed in China. Apart from an occasional report in the medical literature, there is little easily accessible information about Chinese human… Continue reading Everything You Always Wanted to Know About Clinical Research in China, But Were Afraid to Ask

Ethics, Phase 1 Trials, and the Developing World

Under what conditions is it ethical to perform phase 1, translational clinical trials in low and middle-income countries? Together with lead author Alex John London (Carnegie Mellon, Philosophy), I attempt to answer that question in the July 5 issue of Lancet (“Justice in Translation: From Bench to Bedside in the Developing World”). The article makes… Continue reading Ethics, Phase 1 Trials, and the Developing World

Published
Categorized as Uncategorized Tagged ,